Covered recipient · General Payments record
INJA KIM
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$11,020.36
- Reported across 174 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $964.58 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bausch & Lomb Americas Inc. | $358.28 | 3 |
| Oyster Point Pharma, Inc. | $186.74 | 3 |
| Alcon Laboratories Inc | $153.44 | 2 |
| Galderma Laboratories, L.P. | $124.99 | 1 |
| Dompe US, Inc. | $41.72 | 2 |
| RxSight Inc | $40.40 | 2 |
| Astellas Pharma US Inc | $30.09 | 1 |
| ABBVIE INC. | $28.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.92 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104072758 | CMS |
| Alcon Vision LLC | $126.34 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110579973 | CMS |
| Alcon Vision LLC | $27.10 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110579971 | CMS |
| Astellas Pharma US Inc | $30.09 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139450988 | CMS |
| Bausch & Lomb Americas Inc. | $23.87 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140354760 | CMS |
| Bausch & Lomb Americas Inc. | $149.50 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140354758 | CMS |
| Bausch & Lomb Americas Inc. | $184.91 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140354762 | CMS |
| Dompe US, Inc. | $20.21 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151404481 | CMS |
| Dompe US, Inc. | $21.51 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151404483 | CMS |
| Galderma Laboratories, L.P. | $124.99 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145309136 | CMS |
| Oyster Point Pharma, Inc. | $38.28 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147420622 | CMS |
| Oyster Point Pharma, Inc. | $23.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147404314 | CMS |
| Oyster Point Pharma, Inc. | $125.00 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147432217 | CMS |
| RxSight Inc | $18.50 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144219690 | CMS |
| RxSight Inc | $21.90 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144219692 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.